Webinar Targeting Sars Cov 2 A Suite Of Assays To Accelerate Drug Discovery By Reaction Biology

Surface Plasmon Resonance Assay Services Reaction Biology On november 5, 2020, reaction biology shared its recent efforts to support the drug discovery community in a live webinar. To support the drug discovery community with the challenge to identify efficacious covid 19 drugs, we have developed specific assays to block sars cov 2 virus entry and replication.

Sars Cov 2 Protease Assay Services Reaction Biology We offer compound screening assays targeting proteases that are essential for sars cov 2 virus entry and replication. these target proteases include ace2, tmprss2, main protease (mpro), plpro and more. The webinar is going to be split into three sessions, the first session will be a presentation by colby on the recent abveris discovery campaign targeting sars cov 2 spike protein. Two parallel, yet distinct, in vivo approaches for accelerated discovery of antibodies targeting the sars cov 2 spike protein. a single b cell discovery workflow to directly interrogate antibodies secreted from plasma cells for binding specificity and ace2. In this webinar, vanderbilt university medical center researchers dr. robert carnahan and dr. pavlo gilchuk discuss their rapid discovery of highly potent neutralizing antibodies against the sars cov 2 spike protein and the validation of their activity both in vitro and in vivo.

Sars Cov 2 Spike Ace2 Inhibitor Screening Service Reaction Biology Two parallel, yet distinct, in vivo approaches for accelerated discovery of antibodies targeting the sars cov 2 spike protein. a single b cell discovery workflow to directly interrogate antibodies secreted from plasma cells for binding specificity and ace2. In this webinar, vanderbilt university medical center researchers dr. robert carnahan and dr. pavlo gilchuk discuss their rapid discovery of highly potent neutralizing antibodies against the sars cov 2 spike protein and the validation of their activity both in vitro and in vivo. A panel of hts assays have been established to screen for anti sars cov 2 drug leads. We outline our opinions and experiences on key stages in the small molecule drug discovery process: target selection, medicinal chemistry, antiviral assays, animal efficacy and attempts to. We present biochemical protease assays for drug testing against viral proteases (plpro and mpro). we also discussed our spr assays for targeting viral entry. We contributed, amongst others, by the development of a high throughput screening (hts) antiviral assay against sars cov 2 using a fully automated, high containment robot system.

Answering The Call To Address The Covid 19 Pandemic A panel of hts assays have been established to screen for anti sars cov 2 drug leads. We outline our opinions and experiences on key stages in the small molecule drug discovery process: target selection, medicinal chemistry, antiviral assays, animal efficacy and attempts to. We present biochemical protease assays for drug testing against viral proteases (plpro and mpro). we also discussed our spr assays for targeting viral entry. We contributed, amongst others, by the development of a high throughput screening (hts) antiviral assay against sars cov 2 using a fully automated, high containment robot system.